These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12229963)

  • 21. Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection.
    Vakil NB; Traxler BM; Levine D
    Am J Gastroenterol; 2004 Aug; 99(8):1437-41. PubMed ID: 15307856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathology of gastric cardia: a prospective, endoscopic, and morphologic study.
    Cestari R; Villanacci V; Bassotti G; Rossi E; Casa DD; Missale G; Minelli L; Cengia P; Gambarotti M; Pirali F; Donato F; Genta RM
    Am J Surg Pathol; 2007 May; 31(5):706-10. PubMed ID: 17460453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry.
    Chourasia D; Misra A; Tripathi S; Krishnani N; Ghoshal UC
    Indian J Gastroenterol; 2011 Feb; 30(1):12-21. PubMed ID: 21267690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corpus gastritis and erosive esophagitis: a report from the Middle East.
    Contractor QQ; ul Haque I; Saka H; Contractor TQ
    Indian J Gastroenterol; 2006; 25(6):295-7. PubMed ID: 17264429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
    Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
    Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Higher prevalence of obesity in erosive gastroesophageal reflux disease].
    Biccas BN; Lemme EM; Abrahão LJ; Aguero GC; Alvariz A; Schechter RB
    Arq Gastroenterol; 2009; 46(1):15-9. PubMed ID: 19466304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
    Fennerty MB; Johnson DA
    MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
    Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
    Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity does not affect treatment outcomes with proton pump inhibitors.
    Sharma P; Vakil N; Monyak JT; Silberg DG
    J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan.
    Chen TS; Chang FY
    J Clin Gastroenterol; 2007 Oct; 41(9):819-22. PubMed ID: 17881927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis.
    Lightdale CJ; Schmitt C; Hwang C; Hamelin B
    Dig Dis Sci; 2006 May; 51(5):852-7. PubMed ID: 16773434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
    Kindt S; Imschoot J; Tack J
    Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for erosive esophagitis and Barrett's esophagus in a high Helicobacter pylori prevalence area.
    Jonaitis L; Kriukas D; Kiudelis G; Kupčinskas L
    Medicina (Kaunas); 2011; 47(8):434-9. PubMed ID: 22123558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis.
    Schmitt C; Lightdale CJ; Hwang C; Hamelin B
    Dig Dis Sci; 2006 May; 51(5):844-50. PubMed ID: 16642422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Helicobacter pylori eradication on reflux esophagitis therapy: a multi-center randomized control study.
    Xue Y; Zhou LY; Lin SR; Hou XH; Li ZS; Chen MH; Yan XE; Meng LM; Zhang J; Lu JJ
    Chin Med J (Engl); 2015 Apr; 128(8):995-9. PubMed ID: 25881589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma.
    Yamaguchi K; Iwakiri R; Hara M; Kikkawa A; Fujise T; Ootani H; Shimoda R; Tsunada S; Sakata H; Ushiyama O; Koarada S; Tada Y; Nagasawa K; Fujimoto K
    Intern Med; 2008; 47(18):1555-9. PubMed ID: 18797112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease.
    Lai CH; Poon SK; Chen YC; Chang CS; Wang WC
    Helicobacter; 2005 Dec; 10(6):577-85. PubMed ID: 16302983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey.
    Bayrakçi B; Kasap E; Kitapçioğlu G; Bor S
    Turk J Gastroenterol; 2008 Sep; 19(3):145-51. PubMed ID: 19115148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.